DK1411936T3 - Anvendelse af thiazolderivater i fremstillingen af et medikament til behandling af kronisk obstruktiv lungesygdom - Google Patents

Anvendelse af thiazolderivater i fremstillingen af et medikament til behandling af kronisk obstruktiv lungesygdom

Info

Publication number
DK1411936T3
DK1411936T3 DK02746098T DK02746098T DK1411936T3 DK 1411936 T3 DK1411936 T3 DK 1411936T3 DK 02746098 T DK02746098 T DK 02746098T DK 02746098 T DK02746098 T DK 02746098T DK 1411936 T3 DK1411936 T3 DK 1411936T3
Authority
DK
Denmark
Prior art keywords
medicament
manufacture
treatment
pulmonary disease
chronic obstructive
Prior art date
Application number
DK02746098T
Other languages
English (en)
Inventor
Kazuo Sekiguchi
Katsumi Ikezono
Kazuhide Ohta
Takashi Maeda
Hisashi Nagamoto
Original Assignee
Otsuka Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharma Co Ltd filed Critical Otsuka Pharma Co Ltd
Application granted granted Critical
Publication of DK1411936T3 publication Critical patent/DK1411936T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • A61K31/427Thiazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
DK02746098T 2001-07-24 2002-07-16 Anvendelse af thiazolderivater i fremstillingen af et medikament til behandling af kronisk obstruktiv lungesygdom DK1411936T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2001222768 2001-07-24

Publications (1)

Publication Number Publication Date
DK1411936T3 true DK1411936T3 (da) 2005-12-27

Family

ID=19056195

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02746098T DK1411936T3 (da) 2001-07-24 2002-07-16 Anvendelse af thiazolderivater i fremstillingen af et medikament til behandling af kronisk obstruktiv lungesygdom

Country Status (16)

Country Link
US (2) US20040147563A1 (da)
EP (1) EP1411936B1 (da)
KR (1) KR100566709B1 (da)
CN (1) CN1267097C (da)
AR (2) AR036179A1 (da)
AT (1) ATE305299T1 (da)
BR (1) BR0208719A (da)
CA (1) CA2441804C (da)
DE (1) DE60206391T2 (da)
DK (1) DK1411936T3 (da)
ES (1) ES2249596T3 (da)
HK (1) HK1077216A1 (da)
MX (1) MXPA04000620A (da)
MY (1) MY128711A (da)
TW (1) TWI302456B (da)
WO (1) WO2003009844A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI394753B (zh) 2006-03-17 2013-05-01 Otsuka Pharma Co Ltd 新穎替妥牟拉(tetomilast)晶體
TWI436761B (zh) * 2006-06-19 2014-05-11 Otsuka Pharma Co Ltd 使用噻唑衍生物之方法
JP2011513203A (ja) * 2008-03-14 2011-04-28 大塚製薬株式会社 Mmp−2及び/又はmmp−9阻害剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2245660T3 (es) 1990-11-30 2006-01-16 Otsuka Pharmaceutical Co., Ltd. Derivados de azol y su utilizacion como inhibidores de los radicales superoxidos.
AU4015497A (en) * 1996-08-26 1998-03-19 Byk Gulden Lomberg Chemische Fabrik Gmbh Thiazole derivatives useful as selective inhibitors of pde-iv
MY128323A (en) * 1996-09-30 2007-01-31 Otsuka Pharma Co Ltd Thiazole derivatives for inhibition of cytokine production and of cell adhesion
US6727364B2 (en) * 2001-04-30 2004-04-27 The Procter & Gamble Company Triazole compounds useful in treating diseases associated with unwanted cytokine activity

Also Published As

Publication number Publication date
AR090619A2 (es) 2014-11-26
AR036179A1 (es) 2004-08-18
CA2441804C (en) 2007-05-08
CN1633295A (zh) 2005-06-29
DE60206391T2 (de) 2006-07-13
DE60206391D1 (de) 2006-02-09
WO2003009844A1 (en) 2003-02-06
EP1411936B1 (en) 2005-09-28
HK1077216A1 (en) 2006-02-10
CA2441804A1 (en) 2003-02-06
US20040147563A1 (en) 2004-07-29
KR20040028749A (ko) 2004-04-03
MY128711A (en) 2007-02-28
MXPA04000620A (es) 2004-06-25
TWI302456B (en) 2008-11-01
KR100566709B1 (ko) 2006-04-03
EP1411936A1 (en) 2004-04-28
CN1267097C (zh) 2006-08-02
BR0208719A (pt) 2004-07-20
ES2249596T3 (es) 2006-04-01
US7932276B2 (en) 2011-04-26
US20080081828A1 (en) 2008-04-03
ATE305299T1 (de) 2005-10-15

Similar Documents

Publication Publication Date Title
CY2014032I1 (el) Νεα φαρμακα για τη θεραπεια της χρονιας αποφρακτικης πνευμονοπαθειας
DK1343773T3 (da) Thiazolderivater til behandling af PPAR-beslægtede forstyrrelser
NO20035157D0 (no) Lungeadministrering av kjemisk modifisert insulin
DK1425001T3 (da) Phenethanolaminderivater til behandling af respiratoriske sygdomme
NO20043000L (no) Et preparat for behandling av nevrocerebrovaskulaere sykdommer
ITMI20000312A0 (it) Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva
NO20033594L (no) Fenetanolamin-derivater for behandling av luftveissykdommer
DK1423381T3 (da) 17beta-hydroxysteroid-dehydrogenase type 3-inhibitorer til behandling af androgenafhængige sygdomme
IL183506A (en) Use of a compound for the preparation of a drug for the treatment of diseases of breast tumors
DE60223278D1 (de) Nicotin- oder isonicotin benzothiazole derivaten
ATE276244T1 (de) Replikationsinhibitoren des respiratorischen synzytialvirus
DK1283708T3 (da) Anvendelse af biguanidderivater til fremstilling af et medikament med sårhelingsvirkning
DK1487828T3 (da) Morpholinyl-urea-derivater til anvendelse til behandling af inflammatoriske sygdomme
IS7163A (is) Aðferðir til meðhöndlunar á lungnasjúkdómi
NO20012831D0 (no) Diazepinoindoler for behandling av kronisk obstruktiv lungesykdom
DK1411936T3 (da) Anvendelse af thiazolderivater i fremstillingen af et medikament til behandling af kronisk obstruktiv lungesygdom
DK1309322T3 (da) Anvendelse af 3-benzoylphenyleddikesyrederivater til behandling af retinale lidelser
NO20043483L (no) Anvendelse av melagatran for fremstilling av et medikament for behandling av type 1 Diabetes mellitus
NO20032006L (no) Anvendelse av melagatran for fremstilling av et medikament for behandling av ischemiske lidelser
JP2005505605A5 (da)
AU4335901A (en) Novel therapeutic treatment of chronic obstructive pulmonary disease
EE200300466A (et) Püridoindolooni derivaatide kasutamine ravimite valmistamiseks
IS2484B (is) Notkun á tilteknum skammti af fondaparínux-natríum til meðhöndlunar á bráðum heilkennum kransæðabilana
DK1474415T3 (da) 1-phenyl-2-heteroaryl-substituerede benzimidazolderivater, deres anvendelse til fremstilling af lægemidler til behandling af immunologiske sygdomme
HK1044884A1 (zh) 使用二氮染酮吲(diazepinoindoles)治療慢性阻塞性肺部疾病